Avrobio Inc Reports Results For The Quarter Ended In December: Earnings Summary

Tectonic Therapeutic

21/03/2024 13:31

* AVROBIO Inc  AVRO.OQ  reported a quarterly adjusted loss
of 20
cents​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -57
cents.  The mean expectation of three analysts for the quarter
was for a loss of 34 cents per share. Wall Street expected
results to range from -50 cents to -15 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * AVROBIO Inc's reported EPS for the quarter was a loss
of 20
cents​.
    * The company reported a quarterly loss of $8.79 million.
    * AVROBIO Inc shares had fallen by 5.9% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 12.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for AVROBIO Inc
is
$2.00 

This summary was machine generated from LSEG data March 21 at
01:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.34          -0.20          Beat
 Sep. 30 2023      -0.28          -0.44          Missed
 Jun. 30 2023      -0.07          -0.37          Missed
 Mar. 31 2023      -0.54          -0.57          Missed